dl cardiac bioage cardiovascular disease risk model (BioAge Labs)
90
Structured Review
BioAge Labs
dl cardiac bioage cardiovascular disease risk model
Dl Cardiac Bioage Cardiovascular Disease Risk Model, supplied by BioAge Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dl+cardiac+bioage+cardiovascular+disease+risk+model/dl+cardiac+bioage+model/pmc11462873-63-42-43
Average 90 stars, based on 1 article reviews
Dl Cardiac Bioage Cardiovascular Disease Risk Model, supplied by BioAge Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dl+cardiac+bioage+cardiovascular+disease+risk+model/dl+cardiac+bioage+model/pmc11462873-63-42-43
Average 90 stars, based on 1 article reviews
dl cardiac bioage cardiovascular disease risk model - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Association of retinal image–based, deep learning cardiac BioAge with telomere length and cardiovascular biomarkers Article Snippet: .. In this cross-sectional cohort study conducted on individuals in the UK Biobank who had relevant biomarker data, retinal images, and leukocyte telomere length data, increasing cardiovascular disease risk, as assessed by both traditional biomarkers, atherosclerotic cardiovascular disease risk scoring, and a DL Article Title: Association of retinal image–based, deep learning cardiac BioAge with telomere length and cardiovascular biomarkers Article Snippet: SIGNIFICANCE: Our retinal image–based deep learning (DL) cardiac biological age (BioAge) model could facilitate fast, accurate, noninvasive screening for cardiovascular disease (CVD) in novel community settings and thus improve outcome with those with limited access to health care services.. PURPOSE: This study aimed to determine whether the results issued by our DL cardiac BioAge model are consistent with the known trends of CVD risk and the biomarker leukocyte telomere length (LTL), in a cohort of individuals from the UK Biobank.. METHODS: A cross-sectional cohort study was conducted using those individuals in the UK Biobank who had LTL data. |